Teturam FST Tablets 0.15g №30: Uses, Precautions, and Side Effects

Teturam FST Tablets 0.15g №30 is a medication used to treat alcohol dependence. It contains disulfiram as its active ingredient, which helps in the management of alcohol addiction.

Ingredients and Composition

The active ingredient in Teturam FST Tablets 0.15g №30 is disulfiram. Each tablet contains 0.15g of disulfiram. The tablets also contain other inactive ingredients such as lactose, starch, and magnesium stearate.

Indications and Uses

Teturam FST Tablets 0.15g №30 is indicated for the treatment of alcohol dependence. It works by causing unpleasant effects when alcohol is consumed, thereby discouraging the individual from drinking. It is important to note that this medication should only be taken under the supervision of a healthcare professional.

Precautions and Side Effects

Before taking Teturam FST Tablets 0.15g №30, it is important to inform your healthcare provider about any allergies or medical conditions you may have. This medication can cause a range of side effects, including drowsiness, nausea, vomiting, and metallic taste in the mouth.

Conclusion

Teturam FST Tablets 0.15g №30 is an effective medication for the treatment of alcohol dependence. However, it is important to use it as directed by a healthcare professional and to be aware of the potential side effects. If you or someone you know is struggling with alcohol addiction, it is important to seek professional help and guidance.

Note: This article is for informational purposes only and should not be considered medical advice.

• Active ingredient: Disulfiram (Teturam) 150 mg
• Excipients: Microcrystalline cellulose
• Excipients: Lactose monohydrate
• Excipients: Magnesium stearate
• Excipients: May include additional tablet-forming agents

Teturam (disulfiram) tablets are taken orally, usually once daily in the morning, with or without food, under strict medical supervision. The typical initial dose and maintenance dose must be individually determined by a physician based on patient condition. Treatment should only be initiated when the patient has abstained from alcohol for at least 12–24 hours. Regular medical check-ups are required throughout the course of therapy.

fawsfgsag